Literature DB >> 29467835

Development of local clinical practice guidelines in the real world: an evolving scene in China.

Joey Sw Kwong1, Xin Sun1.   

Abstract

Keywords:  CLINICAL TRIALS; CORONARY ARTERY DISEASE; INTERVENTIONAL CARDIOLOGY

Year:  2017        PMID： 29467835      PMCID： PMC5818048          DOI： 10.1136/heartasia-2017-010903

Source DB:  PubMed          Journal:  Heart Asia        ISSN： 1759-1104


× No keyword cloud information.
  44 in total

Review 1.  Barriers to translating EU and US CVD guidelines into practice in China.

Authors:  Dong Zhao; Dayi Hu
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

2.  Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study.

Authors:  Qun Meng; Ling Xu; Yaoguang Zhang; Juncheng Qian; Min Cai; Ying Xin; Jun Gao; Ke Xu; J Ties Boerma; Sarah L Barber
Journal:  Lancet       Date:  2012-03-03       Impact factor: 79.321

3.  Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China.

Authors:  Shenshen Li; Yangfeng Wu; Xin Du; Xian Li; Anushka Patel; Eric D Peterson; Fiona Turnbull; Serigne Lo; Laurent Billot; Tracey Laba; Runlin Gao
Journal:  Am Heart J       Date:  2014-12-18       Impact factor: 4.749

4.  [Effects of intracoronary or intravenous tirofiban administration in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention].

Authors:  Xin-chun Yang; Da-peng Zhang; Le-feng Wang; Li Xu; Yong-gui Ge; Hong-shi Wang; Wei-ming Li; Zhu-hua Ni; Kun Xia; Yong Lian; Yong-li Xue; Li-Xiang Ma
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2007-06

Review 5.  The need for multicentre cardiovascular clinical trials in Asia.

Authors:  Joey S W Kwong; Cheuk-Man Yu
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

6.  A randomized comparison of novel biodegradable polymer- and durable polymer-coated cobalt-chromium sirolimus-eluting stents.

Authors:  Yaling Han; Bo Xu; Quanmin Jing; Shuzheng Lu; Lixia Yang; Kai Xu; Yi Li; Jing Li; Changdong Guan; Ajay J Kirtane; Yuejin Yang
Journal:  JACC Cardiovasc Interv       Date:  2014-11-12       Impact factor: 11.195

7.  Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Authors:  Yaling Han; Jincheng Guo; Yang Zheng; Hongyun Zang; Xi Su; Yu Wang; Shaoliang Chen; Tiemin Jiang; Ping Yang; Jiyan Chen; Dongju Jiang; Quanmin Jing; Zhenyang Liang; Haiwei Liu; Xin Zhao; Jing Li; Yi Li; Bo Xu; Gregg W Stone
Journal:  JAMA       Date:  2015-04-07       Impact factor: 56.272

8.  Ticagrelor overcomes high platelet reactivity in patients with acute myocardial infarction or coronary artery in-stent restenosis: a randomized controlled trial.

Authors:  Pan Li; Yawei Yang; Tao Chen; Yu Liu; Ailin Cao; Junmei Liu; Zhuo Wang; Xianxian Zhao; Yongwen Qin; Liping Ma
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

9.  Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction.

Authors:  Shan-Shan Zhou; Feng Tian; Yun-Dai Chen; Jing Wang; Zhi-Jun Sun; Jun Guo; Qin-Hua Jin
Journal:  J Geriatr Cardiol       Date:  2015-03       Impact factor: 3.327

10.  The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design.

Authors:  Xue Du; Yi Pi; Rachel P Dreyer; Jing Li; Xi Li; Nicholas S Downing; Li Li; Fang Feng; Lijuan Zhan; Haibo Zhang; Wenchi Guan; Xiao Xu; Shu-Xia Li; Zhenqiu Lin; Frederick A Masoudi; John A Spertus; Harlan M Krumholz; Lixin Jiang
Journal:  Catheter Cardiovasc Interv       Date:  2016-03-04       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.